Clinical trial
Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type…
NCT00391846 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00391846 |
|---|---|
| Title | Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone |
| Official title | A Randomised, Single Blind, Multicentre, 9-month, Phase IV Study, Comparing Treatment Guided by Clinical Symptoms and Signs and NT-proBNP vs Treatment Guided by Clinical Symptoms and Signs Alone, in Patients With Heart Failure (HF) and Left Ventricular Systolic Dysfunction |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heart Failure, Ventricular Dysfunction, Left |
| Intervention type | Drug, Procedure |
| Interventions | Captopril, Enalapril, Lisinopril, Ramipril, Trandolapril, Bisoprolol, Carvedilol, Metoprolol succinate, Candesartan, Valsartan and 6 more |
| Enrollment | 252 |
| Start date | Oct 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Oct 25, 2006 |
| Last update posted | Jun 25, 2012 |
| Countries | Sweden |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: